Trial · NCT03456752
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Prolonged ileus | Day 30 | Prolonged POI was defined as if two or more of the following five criteria are met on day 4 postoperatively: nausea or vomiting; inability to tolerate an oral diet over last 24 h; absence of flatus over last 24 h; abdominal distension; and radiologic confirmation. |
| Secondary | PONV(Postoperative nausea and vomiting) and additional antiemetics given within 24hr after surgery | 24hr | the incidence of any nausea, emetic episodes (retching or vomiting),or both (i.e., postoperative nausea and vomiting) during the first 24 postoperative hours. |
| Secondary | Postoperative pain on POD 1, 3, and 5 | up to 1 week | Visual analog scale (VAS) for pain description (0-10 visual analogue pain scale) |
| Secondary | Postoperative fagitue score on POD 1, 3, and 5 | up to 1 week | Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue Scale (Version 4). The FACIT-IT score is a 13-item tool that measures an individual's level of fatigue during their usual daily activities over the past week. The level of fatigue is measured on a four point Likert scale (4 = not at all fatigued to 0 = very much fatigued) |
| Secondary | GI-2 recovery | Day 30 | time to upper (first tolerance of solid food) and lower (first bowel movement) GI recovery (GI-2). |
| Secondary | Blood WBC levels, preoperative and on postoperative 1,3 and 5 | Day 30 | Blood WBC levels, preoperative and on postoperative 1,3 and 5 |
| Secondary | Blood neutrophil percentage, preoperative and on postoperative 1,3 and 5 | Day 30 | Blood neutrophil percentage, preoperative and on postoperative 1,3 and 5 |
| Secondary | Serum C-reactive protein (CRP) level, preopperative and on postoperative 1,3 and 5 | Day 30 | Serum C-reactive protein (CRP) level, preopperative and on postoperative 1,3 and Serum C-reactive protein (CRP) level, preopperative and on postoperative 1,3 and Serum C-reactive protein (CRP) level, preopperative and on postoperative 1,3 and Serum C-reactive protein (CRP) level, preopperative and on postoperative 1,3 and |
| Secondary | Serum Interleukin-6 (IL-6) level, preopperative and on postoperative 1,3 and 5 | Day 30 | Serum Interleukin-6 (IL-6) level, preopperative and on postoperative 1,3 and 5 |
| Secondary | Serum procalcitonin (PCT) level, preopperative and on postoperative 1,3 and 5 | Day 30 | Serum procalcitonin (PCT) level, preopperative and on postoperative 1,3 and 5 |
| Secondary | Body composition, preoperative and on POD 1 | Day 30 | body composition was determined using Bioelectrical impedance analysis (BIA) |
| Secondary | Postoperative length of stay | Day 90 | in days |
| Secondary | Postoperative morbidity | Day 30 | Documented using comprehensive complication index(CCI) |
| Secondary | Postoperative surgical site infections (SSIs) | Day 30 | Including superficial SSIs and deep SSIs. |
| Secondary | Overall cost of treatment | up to 1 year | In Chinese Yuan (CNY) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03456752/registered